MedTrace Logo

Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan

NCT03208543 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2019-01-16

No results posted yet for this study

Summary

This research studies the effect thermotherapy as treatment of Old World CL which is not invasive, non-toxic, and the short treatment. While the current standard treatment comprise daily painful injections with antimonials,

Conditions

  • Cutaneous Leishmaniases

Interventions

DEVICE

HECT-CL

To evaluate the effectiveness, safety and feasibility of thermotherapy with the low cost Hand-held Exothermic Crystallization Thermotherapy pad in the treatment of cutaneous leishmaniasis in Quetta, Balochistan, Pakistan.

Sponsors & Collaborators

  • Medecins Sans Frontieres, Netherlands

    lead OTHER

Principal Investigators

  • Koert Ritmeijer, PhD · Medecins Sans Frontieres, Netherlands

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-04
Primary Completion
2017-12-20
Completion
2017-12-20

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03208543 on ClinicalTrials.gov